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a b s t r a c t
Background: Insertable cardiac monitors (ICMs) are often used for long-term monitoring of cardiac
rhythm. The Medtronic’s LINQ Reveal ™ is a new generation wireless, automated, and patient responsive
subcutaneous ECG monitoring device. Despite several advantages to its small size we have noted an
unusually high incidence of extrusion at our center.
Methods: & Results: We conducted a retrospective case analysis to review Reveal LINQs implanted at our
center. All devices were inserted using the provided insertion tools. Patients with extruded devices were
identified and details regarding the site and technique of insertion, incision closure, use of peri-operative
antibiotics, and follow-up details were collected. 81 patients underwent 85 Reveal LINQ implants at a
tertiary care University Hospital referral center. The most common reason for implant was suspected
arrhythmia with or without structural heart disease or unexplained syncope. There were 4 spontaneous
extrusions occurring within 7e24 days after insertion with an incidence rate of 4.7%. One extruded
device was anchored to subcutaneous tissue, and no pocket/device infections or hematomas were noted.
Conclusions: Device migration and erosion through skin are important potential adverse events for the
Reveal LINQ implantable loop recorder. This study reports an unexpectedly high rate of extrusion without
infection. The authors suggest that the depth of the incision is the main factor impacting extrusions.
Larger studies are recommended, however, and a proposed measure to avoid spontaneous extrusion is
the design of a longer manufacturer’s blade in order to increase the depth of the incision and insertion.
Copyright © 2020, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Implantable cardiac monitors (ICMs) have been used for years
for long-term monitoring of cardiac rhythm in patients with or
without known arrhythmias or structural heart disease [1]. The
Medtronic’s LINQ Reveal ™ is a new generation wireless, auto-
mated, and patient responsive subcutaneous ECG monitoring de-
vice 87% smaller than its predecessor measuring 1 cc in size. It is
placed in the subcutaneous plane utilizing the manufacturer’s tool
[2] As compared to its predecessor, its minimally invasive tech-
nique of implantation allows for the potential of implant in an
outpatient setting, improved patient comfort, speedy recovery, and
reduction in implantation costs. Despite several advantages to a
small size, the authors have noted an unusually high incidence of
extrusion. This study seeks to evaluate the extrusion rate and fac-
tors contributing to extrusion in this population of patients.
2. Method
2.1. Study design
Single center retrospective observational study on patients un-
dergoing new generation Reveal LINQ implant at a tertiary care
university hospital.
Patient demographics, indication for implant, medications, peri-
procedural data including site of insertion, duration of implant,
technique utilized for insertion, wound closure, use of peri or post-
operative antibiotics and follow up details were noted. The study
was approved by the Institutional Review Board.
* Corresponding author. 841 Prudential Drive, Jacksonville, FL, 32207, USA.
E-mail address: Sunita.ferns@jax.ufl.edu (S.J. Ferns).
Peer review under responsibility of Indian Heart Rhythm Society.
Contents lists available at ScienceDirect
Indian Pacing and Electrophysiology Journal
journal homepage: www.elsevier .com/locate/ IPEJ
https://doi.org/10.1016/j.ipej.2020.04.005
0972-6292/Copyright © 2020, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Indian Pacing and Electrophysiology Journal 20 (2020) 189e192
Downloaded for Anonymous User (n/a) at Washington University in Saint Louis Bernard Becker Medical Library from ClinicalKey.com by Elsevier on October 07, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
2.2. Device implantation
All devices were implanted in the EP lab and not in an outpatient
setting. In all cases implants were performed by electrophysiolo-
gists trained in the technique. The implant was performed using the
provided insertion and incision tools and in accordance with the
recommendations in the manufactures guidelines [2]. Local anes-
thesia was administered in most cases with the use of conscious
sedation in a very small subgroup. Standard aseptic precautions
were utilized in accord with hospital policies for device implants.
These included use of a cap, mask, sterile gown and glove use by all
staff members involved in the procedure. Skin preparation included
the use of a chlorhexidine swab and a sterile drape. The LINQ tool
was used to make the incision at a 45 angle to the subcutaneous
plane (Fig. 1). The device was then injected into the pocket using
the preloaded tool. Limitations in the length of the insertion tool
made a deep incision difficult and therefore we used a size 11 blade
to deepen the pocket in our teenage and adult patients. The tool
was removed and the pocket was closed using an absorbable sub-
cutaneous suture as well as a variety of superficial incision closure
techniques noted in the results below. Peri-procedural antibiotics,
were administered on a case by case basis. In patients that received
post-operative prophylaxis, oral antibiotics were administered for 3
days.
2.3. Follow up
All patients underwent a routine wound check at our device
clinic or with their primary care physician within 10e14 days of
insertion. Patients were advised to keep thewound dry for at least 5
days post implantation. Wound non-closure was deemed to have
occurred if the incision reopened with the device protruding
through Fig. 2. Device hematoma was diagnosed if there was blood
accumulation in the pocket leading to swelling, pain and discolor-
ation. Device infection was diagnosed if the patient had purulent
discharge, pain, or fever and signs of infection such as non-
approximation of the wound, redness, or tenderness. Wound cul-
tures were sent as indicated.
2.4. Statistical analysis
All data is expressed as mean (SD) for continuous variables.
Categorical variables are represented as proportions. Continuous
variables were analyzed using a student t-test when normally
distributed and a Mann Whitney U test for non-normal distribu-
tions. Categorical variables were analyzed with a chi-square test.
Analytical conclusions were limited by small numbers in the group
with the spontaneous extrusion.
3. Results
81 patients underwent 85 Reveal LINQ implants at a tertiary
care University Hospital referral center during a two year period.
Patient demographics and study characteristics are detailed in
Table 1. The most common reason for implant was suspected
arrhythmiawith or without structural heart disease or unexplained
syncope (Table 1). There were 4 spontaneous extrusions of devices
in three patients occurring within 7e24 days after insertionwith an
incidence rate of 4.7%. There was slight variability in the technique
of pocket closure noted in each case. In every case the skin edges
were opposed with an absorbable subcutaneous suture as well as
superficial closure using either topical skin adhesive, steri strips, or
staples. In one case with a device extrusion the device was physi-
cally anchored to the subcutaneous tissue in the pocket with
absorbable suture material. Two patients were on chronic anti-
coagulation, however, the wound was noted to be hemostatic
despite the extrusion. All extrusions were reported to be pain free.
There were no device or pocket infections noted in any case
(Table 2).
4. Discussion
Implantable cardiac monitors are important tools for the
detection of arrhythmias in patients with infrequent symptoms [1].
In addition to being a useful diagnostic tool, implantable devices
also play an important role in monitoring activity of known and
Fig. 1. a,b: Technique of implantation. Fig. 2. Extrusion, view from patient’s left.
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medically managed arrhythmias. They are useful for tailoring
therapy in patients with atrial fibrillation or for risk stratification
after a myocardial infarction [3e6]. Because of the ease of subcu-
taneous implantation and their ability to monitor continuously for
long periods of time, they have become an important tool for the
electrophysiologist. An implied imperative to the effectiveness of
ICMs are that they remain a stable and reliable method of cardiac
rhythm monitoring e namely, they need to stay inside the patient.
Though the Reveal LINQ has been used widely in the last three
years since its availability, data regarding complications in the LINQ
are relatively few. The three large multicenter trials on Reveal LINQ
usability do not report spontaneous extrusion as a complication
[7,8]. Our study highlights a relatively high incidence of sponta-
neous extrusion of the Reveal LINQ compared to the investigator
trials. Two of the extrusions occurred in a pediatric patient with
scant subcutaneous tissue and two adult patients were on chronic
anti-coagulation. The number of extrusions, however, were too
small to draw any meaningful statistical conclusions. We also
highlight the differences in technique with closure and peri-
procedural antibiotic use within our institution but note that
these do not seem to impact device extrusion.
All of our cases were performed using the Medtronic preferred
location and tool [2]. Lakkireddy et al. have shown a higher inci-
dence of overall complications and infection rate when using the
manufacturer’s method of insertion. They hypothesize that the
wide mouth large beveled edge created by the relatively shallow
and wide manufacturers tool, if not sutured, can open up leading to
spontaneous extrusion and have recommended a suture placement
in order to minimize this risk [9]. The device manual recommends
using a suture to secure the device to underlying tissue, if deemed
necessary, and recommends site closure using any method
preferred by the provider [2]. Unlike the older generation device,
the small size of the skin incisionwith the device in a subcutaneous
location can make a suture placement challenging. There is
currently wide variability in reported methods used to secure the
device and close the pocket for the LINQ. Two prospective trials
report the use of either sutures, staples, surgical glue, or adhesive
strips or some combination of these methods [7,8]. The authors in
this study have not noted a difference in extrusions based on type
of closure used. In fact, two of four devices that were extruded in
the study were sutured down.
All patients in the current study had the device implanted in the
manufacturers preferred location. In the Usability and Investigator
trial the manufacturer’s preferred location was used by 77.2 and
92.1% providers, respectively [7]. Different device insertion loca-
tions may be chosen depending on the patient’s body habitus and
amount of subcutaneous or breast tissue. Based on the limited
available data, however, there has been no identified difference in
outcomes based on chosen site for insertion [7,8].
The authors do feel that the depth of the incision makes a dif-
ference to the extrusion rate. The tool provided does not allow for a
sufficiently deep incision and one way to overcome this limitation
is the use of size 11 blade. Moreover the thickness of skin that an
operator can pinch before deploying the tool may also affect
placement and help with device deployment in a deeper plane.
Chaouki et al. have reported the only other instance of sponta-
neous device extrusion in a child [10].They hypothesized that the
device migrated due to a smaller subcutaneous pocket in a young
child. Two of the extrusions in the current study occurred in a
pediatric patient with relatively scant subcutaneous tissue as
compared to other pediatric patients in the study.
A recent study by Gundaa et al. compared infection rates in
Reveal LINQ as compared to the Reveal XT and found a higher rate
of infection at 12% in the LINQ group. The Reveal LINQ investigator
trials report an infection rate ranging from 0.8 to 3% and no ex-
trusions [7,8,11]. Despite a high spontaneous extrusion rate in the
current study, there were no infections. The authors feel that their
Table 1
Study population characteristics.
Patient Characteristics Non extruded Extruded P value
Age 54 (49.4e58.4) 39.6 (17.6e97) 0.18
Sex(F:M) 33:48 2:2 e
Weight 90.7 (84.7e96.5) 68.2 (13.8e150.2) 0.12
Height 173.2 (170e176.3) 154.5 (91.9e217.1) 0.4
BMI 29.98 (28.21e31.75) 24.14 (10.4e37.9) 0.27
Race
 Caucasian 66 4 e
 Hispanic 4 0
 African-American 9 0
 Other 1 0
Comorbid conditions
 Diabetic 16 1 e
 Renal failure 3 1
 Other chronic illness 38 0
Hospitalization 18 0
Anticoagulants
 NOACS 19 1 e
 Coumadin 10 1
Blood thinners
 Aspirin 17 0
 Plavix 2 0
INR on warfarin 1.3 (1.1e1.4) e e
Use of antibiotics
 Pre and post procedure 3 0 e
 Pre procedure 35 3
 Post procedure 5 0
 None 37 1
Indication for implant
 Palpitations 41 3 e
 Syncope 35 1
 Pre-syncope 1 0
 Cryptogenic stroke 3 0
Procedure Time(mins) 7.41 (6.29e8.53) 7.5 (1.5e15) 0.97
Superficial closure technique
 Sutures 28 1 e
 Dermabond glue 30 3
 Steristrips 20 0
 Staples 1 0
Table 2














1 74 M 2.2 Syncope 3 No Yes Dermabond Coronary artery disease, hypertension, hyperlipidemia,
hypothyroidism
2 67 M 2.6 Palpitation 10 Yes Yes Suture and
Dermabond
No
3 8 F 0.9 Palpitation 4 Yes No Dermabond Genetic arrhythmic syndrome
4 8.5 F 0.9 Palpitation 13 Yes No Suture and
Dermabond
Genetic arrhythmic syndrome
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utilization of similar aseptic techniques for the implantable loop
recorders as those for transvenous devices have contributed to
their low infection rate. The use of prophylactic antibiotics during
implantable loop procedures is a carryover of the common practice
used with therapeutic cardiac implantable electronic devices. As
such, the manufacturer’s guidelines for the Reveal LINQ do not
specifically recommend a practice and it is often left to the clinical
judgement of the operator. One of the larger multicenter registry
studies report that two-thirds of patients do not receive pre-
procedural antibiotics and yet have an extremely low infection
rate of 0.8% [9]. The use of prophylactic antibiotics with the Reveal
LINQ has been reported at about 50% in both the investigator trial
group and Gundaa et al. [7,8]. The current study shows a similar
figure with the use of antibiotics in 54% of patients with no in-
fections noted irrespective of whether antibiotics were used. The
data so far would suggest that it may be safe to not administer
antibiotics prophylactically in loop implants.
5. Conclusion
Device migration and erosion through the skin are important
potential adverse events for the reveal LINQ implantable loop
recorder. The current study reports an unexpectedly high rate of
extrusion without infection in this study. They authors do feel that
the depth of the incision is the main factor impacting extrusions.
Proposed measures to avoid spontaneous extrusion in this popu-
lation includes design of a longer manufacturer’s blade in order to
increase the depth of the incision.
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